Maxgalin M 50 Capsule is a combination pharmaceutical formulation containing Methylcobalamin 500 mcg and Pregabalin 50 mg, designed for the management of neuropathic pain and associated neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath formation and enhancing neuronal function. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing the release of excitatory neurotransmitters and alleviating neuropathic pain, seizures, and anxiety. Maxgalin M 50 is indicated for conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and neuropathic pain associated with spinal cord injury. The combination provides synergistic benefits by addressing both nerve repair and pain modulation. It is generally well-tolerated; however, patients should be monitored for potential side effects including dizziness, somnolence, and gastrointestinal disturbances. Dosage and duration of therapy should be individualized based on clinical response and tolerability. Maxgalin M 50 Capsule should be used under medical supervision, with caution advised in patients with renal impairment or a history of hypersensitivity to its components.